Schering-Plough Afrin, Lotrimin GMP Shortcomings Cited In FDA-483 Report

25 Jun 2001

• By The Tan Sheet

Batch validations at a Schering-Plough manufacturing site in Puerto Rico uncovered several problems related to Afrin nasal spray and Lotrimin antifungal, FDA-483 inspection reports show.

Schering-Plough Afrin, Lotrimin GMP Shortcomings Cited In FDA-483 Report

More from Archive

More from Pink Sheet